Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer

Published:2006-11-06 Issue:46 Volume:103 Page:17426-17431
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Pieretti-Vanmarcke R.,Donahoe P. K.,Pearsall L. A.,Dinulescu D. M.,Connolly D. C.,Halpern E. F.,Seiden M. V.,MacLaughlin D. T.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference62 articles.

1. Müllerian Inhibiting Substance as a Marker for Ovarian Sex-Cord Tumor

2. Diagnostic Utility of Müllerian Inhibiting Substance Determination in Patients with Primary and Recurrent Granulosa Cell Tumors

3. Measurements of Serum Müllerian Inhibiting Substance in the Evaluation of Children with Nonpalpable Gonads

4. Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of AMH on primordial follicle populations in mouse ovaries and human pre-pubertal ovarian xenografts during doxorubicin treatment;Frontiers in Cell and Developmental Biology;2024-08-27

2. Anti-Müllerian hormone – clinical use and future possibilities;Česká gynekologie;2023-04-21

3. Anti-Müllerian Hormone Type II Receptor Expression in Endometrial Cancer Tissue;Cells;2020-10-17

4. Anti-Müllerian Hormone Expression in Endometrial Cancer Tissue;International Journal of Molecular Sciences;2019-03-15

5. The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages;Oncotarget;2017-10-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3